Pharma Journalist
  • facebook
  • twitter
  • google_plus
  • Email
Pharma Journalist

2nd T-Cell Engager for Autoimmune Disease Summit to Deliver 3 Days of Expert-Led Content to Advance Autoimmune TCE Strategy

Fulcrum and Slate Medicines Agree to $245 Million Merger

LEO Pharma Acquires Dersimelagon Rights for Rare Skin Diseases

FDA Approves Veklury (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis

Read more

Exclusive interview with AstraZeneca on the future of oligonucleotide drug development

Read more

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Zolbetuximab

Read more

Gilead Partners with CHAI and Penta to Improve Treatment and Adherence Rates Among Children with HIV in Low and Middle Income Countries

Read more

 Entrada to receive $224 million upfront payment and $26 million equity investment

Read more

InnoCare and ArriVent Announce Clinical Development Collaboration

Read more

TheracosBio Announces Commercial Availability of Brenzavvy (bexagliflozin) for the Treatment of Adults with Type 2 Diabetes

Read more

BeiGene Announces FDA Acceptance of sNDA for Fifth BRUKINSA Indication

Read more

LianBio Announces Clinical Supply Agreement with AstraZeneca in China to Evaluate BBP-398 in Combination with Osimertinib in Patients with Non-Small Cell Lung Cancer with EGFR Mutations

Read more

FDA approves expanded indication for Novartis Leqvio (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease

Read more

Posts pagination

Previous Page 1 of 946 … Page 180 of 946 … Page 946 of 946 Next
  • About
  • Advertise
  • Subscribe
  • Contact
View Desktop Version